Methods of diagnosing and treating small intestinal...

Details Methods of diagnosing and treating small intestinal... Methods of diagnosing and treating small intestinal...

2006-05-23

2006-05-23

Swartz, Rodney P (Department: 1645)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Testing efficacy or toxicity of a compound or composition

C424S009100, C424S116000, C424S278100, C424S439000, C426S002000, C426S071000, C426S658000, C426S800000, C426S801000, C435S004000, C435S029000

Reexamination Certificate

active

07048906

ABSTRACT:
Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.

REFERENCES:
patent: 4611011 (1986-09-01), Yelnosky et al.
patent: 4673680 (1987-06-01), Pendleton
patent: 4701457 (1987-10-01), Yelnosky et al.
patent: 4970207 (1990-11-01), Sato et al.
patent: 4990617 (1991-02-01), Boswell et al.
patent: 5041431 (1991-08-01), Halskov
patent: 5063245 (1991-11-01), Abreu et al.
patent: 5064858 (1991-11-01), Sapse
patent: 5120306 (1992-06-01), Gosselin
patent: 5219871 (1993-06-01), Cross et al.
patent: 5225352 (1993-07-01), Zanetta et al.
patent: 5225407 (1993-07-01), Oakley et al.
patent: 5236901 (1993-08-01), Burks et al.
patent: 5354757 (1994-10-01), Flynn et al.
patent: 5380522 (1995-01-01), Day
patent: 5426028 (1995-06-01), Levy et al.
patent: 5434174 (1995-07-01), Gidda et al.
patent: 5443826 (1995-08-01), Borody
patent: 5453428 (1995-09-01), Kaminski
patent: 5519014 (1996-05-01), Borody
patent: 5538856 (1996-07-01), Levy et al.
patent: 5547961 (1996-08-01), Ohta et al.
patent: 5550132 (1996-08-01), Benson et al.
patent: 5589168 (1996-12-01), Allen et al.
patent: 5599795 (1997-02-01), McCann et al.
patent: 5612366 (1997-03-01), Becker et al.
patent: 5627200 (1997-05-01), Kreutter et al.
patent: 5645997 (1997-07-01), Kline et al.
patent: 5648355 (1997-07-01), Theoharides
patent: 5648359 (1997-07-01), Ohashi et al.
patent: 5660828 (1997-08-01), Rodriguez et al.
patent: 5668143 (1997-09-01), Ku et al.
patent: 5677326 (1997-10-01), Tsuchiya et al.
patent: 5679684 (1997-10-01), Benson et al.
patent: 5684017 (1997-11-01), Harrison et al.
patent: 5703100 (1997-12-01), McDonald et al.
patent: 5707642 (1998-01-01), Yue
patent: 5726187 (1998-03-01), Gaster et al.
patent: 5728380 (1998-03-01), Allen et al.
patent: 5736560 (1998-04-01), Cosford et al.
patent: 5753218 (1998-05-01), Smith et al.
patent: 5759546 (1998-06-01), Weinberg et al.
patent: 5760032 (1998-06-01), Kitajima et al.
patent: 5776524 (1998-07-01), Reinhart
patent: 5780026 (1998-07-01), Yoshii et al.
patent: 5821259 (1998-10-01), Theoharides
patent: 5830668 (1998-11-01), Mordechai et al.
patent: 5833987 (1998-11-01), Noelle et al.
patent: 5834215 (1998-11-01), Garry et al.
patent: 5846933 (1998-12-01), Korngold et al.
patent: 5852041 (1998-12-01), Cosford et al.
patent: 5858403 (1999-01-01), Borody et al.
patent: 5861398 (1999-01-01), Rabinovich et al.
patent: 5863529 (1999-01-01), Rodriguez
patent: 5863552 (1999-01-01), Yue
patent: 5869262 (1999-02-01), Gallatin et al.
patent: 5916869 (1999-06-01), Croom, Jr. et al.
patent: 98/56397 (1998-12-01), None
patent: 85/02840 (1999-07-01), None
Costello, et al.,The effect of an elemental diet on stool output in irritable bowel syndrome, Proceedings of the Nutrition Societyvol. 53, No. 3 pp. 223A (1994).
Morisse, et al.,Effect of a Fructo-Oligo-Saccharides Compound in Rabbits Experimentally Infected With E. coli, Journal of Applied Rabbit Researchvol. 15 pp. 1137-1143 (1992).
Young, G.,Colorectal disorders: A Dietary management perspective, Asia Pacific J. Clin Nutr.vol. 9 (Suppl.), pp. S76-S82 (2000).
Cummings, J. H. et al.,The control and consequences of bacterial fermentation in the human colon, J. of Applied Bacteriologyvol. 70 pp. 443-459 (1991).
Simpson, J. W.,Diet and Large Intestinal Disease in Dogs and Cats, J. of Nutritionvol. 128 pp. 2717S-2722S (1998).
XP-000980196 Raymond Karcher, Ph.D., et alUsing a Cutoff of <10ppm for Breath Hydrogen Testing: A Review of Five Years Experience, Annals of Clinical and Laboratory Science,vol. 29, No. 1. pp. 1-8 (Jan. 1999).
XP-000980200 Yuji Funayma, et al.Anti-bacterial Treatment for Postoperative Bacterial Overgrowth in Crohn's Disease, Gastroenterology,vol. 112, No. 4 Supp., p. A1444 (1997) SSAT Abstracts.
XP-002159720 G. Galatola et al.,Diagnosis of Bacterial Contamination of the Small Intestine Using the 1 g ′14C! Xylose Breath Test in Various Gastrointestinal Diseases, Minerva Gastroenterol. Dietol.,vol. 37, pp. 169-175, (1991), Abstract Only.
XP-000980123 S. A. Albano et al.,Small Intestinal Bacterial Overgrowth in Systemic Lupus Erythematosus(SLE),Arthritis&Rheumatism,vol. 42, No. 9 Suppl., p. S305, Abstract 1409a (Nov. 13-14, 1999).
XP-000979785 C. Prantera et al.,An Antibiotic Regimen for the Treatment of Active Crohn's Disease: A Randomized, Controlled Clinical Trial of Metronidazole plus Ciprofloxacin, The American Journal of Gastroenterology,vol. 91, No. 2, pp. 328-332 (1996).
XP-000979794 F. Casellas et al.,Potential Usefulness of Hydrogen Breath Test with d-Xylose in Clinical Management of Intestinal Malabsorption, Digestive Diseases and Sciences,vol. 38, No. 2, pp. 321-327 (Feb. 1993).
XP-000981761 A. Schneider et al.,Value of the 14C-D-Xylose Breath Test in Patients with Intestinal Bacterial Overgrowth,Digestion, 32:86-91 (1985).
XP-000980122 M. Pimental et al.,Eradication of Small Intestinal Bacterial Overgrowth Decreases Symptoms in Fibromyalgia: A Double Blind Randomized Study, Arthritis&Rheumatism,vol. 42, No. 9 Suppl., p. S343, Abstract 1632 (Nov. 13-14, 1999).
International Search Report, mailed Oct. 18, 2001 regarding PCT/US01/11238.
Annese, V. et al..,Gastrointestinal motility disorders in patients with inactive Crohn's disease, Scand J Gastroenterol,32(11):1107-17 (Nov. 1997). Abstract Only.
Autschbach, F. et al.,In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease, Am J Pathol,153(1):121-30 (Jul. 1998). Abstract Only.
Babystsky, M.W. et al.,Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease, Gastroenterology,110(4):975-84 (Apr. 1996). Abstract Only.
Bell, Iris R. et al.,Illness from Low Levels of Enviromental Chemicals: Relevance to Chronic Fatigue Syndrome and Fibromyalgia, The American Journal of Medicine,vol. 105 (3A), pp. 74S-84S (Sep. 28, 1998).
Bennett, G. et al.,Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils, Pain,77:315-322 (1998).
Bjornsson, E. S.,comparison between physiologic and erythromycin-induced interdigestive motility, Scand J. Gastroenterol30(2):139-45 (Feb. 1995). Abstract Only.
Bruin, K. F. et al.,Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases, Eur J. Gastroenterol Hepatol,7(8):791-5 (Aug. 1995) Abstract Only.
Bruno, Richard L. et al.,Parallels Between Post-Polio Fatigue and Chronic Fatigue Syndrome: A Common Pathophysiology?, The American Journal of Medicine,105(3A):66S-73S (1998).
Camoglio, L. et al.,Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease, Inflamm Bowel Dis,4(4):285-90 (Nov. 1998). Abstract Only.
Casafont, Morencos F. et al.,Small bowel bactrial overgrowth in patients with alcoholic cirrhosis, Dig Dis Sci,41 (3):552-6 (Mar. 1996). Abstract Only.
Casini-Raggi, V. et al.,Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflamation,J Immunol, 154(5):2434-40 (Mar. 1, 1995). Abstract Only.
Castedal M.,Postprandial peristalsis in the human duodenum, Neurogastroenterol Motil,10(3):227-33 (Jun. 1998). Abstract Only.
Chang C. S., et al.,Small intestine dysmotility and bacterial overgrowth in cirrhotic patinets with spontaneous bacterial peritonitis, Hepatology,28(5):1187-90 (Nov. 1998). Abstract Only.
Chang, C. S.,Increa

Affiliated with

Also associated with

Rating

Methods of diagnosing and treating small intestinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of diagnosing and treating small intestinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of diagnosing and treating small intestinal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3596371